Henry Redel
Impact in
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases
- Physiology top 10%
- Adipose Tissue and Metabolism
Papers in
-
- COVID-19 Clinical Research Studies 2
- Viral gastroenteritis research and epidemiology 1
- Clostridium difficile and Clostridium perfringens research 1
-
- Phenothiazines and Benzothiazines Synthesis and Activities 1
- Co-authors
- Netta Sion‐Vardy (1 shared paper)Nora Klöting (1 shared paper)Eliezer Avinoach (1 shared paper)Michael Stümvoll (1 shared paper)Shira Ovadia (1 shared paper)Iris Shai (1 shared paper)Nava Bashan (1 shared paper)Ilana Harman‐Boehm (1 shared paper)
- Journals
- The Journal of Infectious Diseases (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Open Forum Infectious Diseases (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Emerging infectious diseases (1 paper)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Henry Redel
7 papers receiving 587 citations
Peers
Comparison fields: 5 of 86
- Epidemiology 291
- Physiology 206
- Rehabilitation 40
- Cardiology and Cardiovascular Medicine 104
- Endocrinology, Diabetes and Metabolism 60
Countries citing papers authored by Henry Redel
This map shows the geographic impact of Henry Redel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Redel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Redel more than expected).
Fields of papers citing papers by Henry Redel
This network shows the impact of papers produced by Henry Redel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Redel. The network helps show where Henry Redel may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Redel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 457 | |
| 2 | 2013 | 87 | |
| 3 | 2013 | 36 | |
| 4 | 2019 | 15 | |
| 5 | 2016 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 1 | |
| 8 | 2024 | 0 |
About Henry Redel
Henry Redel is a scholar working on Infectious Diseases, Molecular Biology, Neurology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 8 papers that have together received 601 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Autoimmune and Inflammatory Disorders Research (1 paper), Viral gastroenteritis research and epidemiology (1 paper), Clostridium difficile and Clostridium perfringens research (1 paper), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Malaria Research and Control (1 paper), Diabetes and associated disorders (1 paper) and Mosquito-borne diseases and control (1 paper). The work is most often cited by research in Epidemiology (291 citations), Physiology (206 citations), Rehabilitation (40 citations), Cardiology and Cardiovascular Medicine (104 citations) and Endocrinology, Diabetes and Metabolism (60 citations). Henry Redel has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Netta Sion‐Vardy, Nora Klöting, Eliezer Avinoach, Michael Stümvoll, Shira Ovadia, Iris Shai, Nava Bashan, Ilana Harman‐Boehm, Matthias Blüher and Assaf Rudich. Their work appears in journals such as The Journal of Infectious Diseases, Frontiers in Cellular and Infection Microbiology, Open Forum Infectious Diseases, The Journal of Clinical Endocrinology & Metabolism and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.